Accord Healthcare Polska Limited Liability Company Accord Healthcare Single Member Corporation Laboratori Fundació Dau Pharmadox Healthcare Ltd.

Poland

All drugs from this manufacturer

  • BICALUTAMIDE ACCORD

    This medicine is used in adult men to treat non-metastatic prostate cancer when castration or other treatment methods are not possible or cannot be used. It may also be used in combination with radiotherapy or surgery.

    Dosage form: tablets, film-coated

    Active substance Dosage
    bicalutamide 150 mg

    ATC: L02BB03

  • The medicinal product is used in adults, as well as in children and adolescents (from 1 to 17 years of age) for the treatment of skin and subcutaneous tissue infections and bloodstream infections associated with skin infections. In adults, it is also used for the treatment of heart infections (endocarditis) and bloodstream infections caused by Staphylococcus aureus bacteria.

    Dosage form: powder for preparation of solution for injection / infusion

    Active substance Dosage
    daptomycin 350 mg

    ATC: J01XX09

  • The medicinal product is used to prevent nausea and vomiting caused by chemotherapy (in adults and children over 6 months of age) and radiotherapy (in adults). It is also used to prevent and treat postoperative nausea and vomiting (in adults and children over 1 month of age).

    Dosage form: solution for injection or infusion in ampoule-syringe

    Active substance Dosage
    ondansetron hydrochloride dihydrate 4.98 mg

    ATC: A04AA01

  • The medicine is used to prevent nausea and vomiting caused by chemotherapy (in adults and children over 6 months of age) and radiotherapy (in adults). It is also used to prevent and treat postoperative nausea and vomiting (in adults and children over 1 month of age).

    Dosage form: solution for injection or infusion in ampoule-syringe

    Active substance Dosage
    ondansetron hydrochloride dihydrate 9.96 mg

    ATC: A04AA01